Compass Ion Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
4,774
-104
-2% -$9.49K 0.04% 205
2026
Q1
$501K Sell
4,878
-291
-6% -$32.9K 0.05% 177
2025
Q4
$648K Sell
5,169
-264
-5% -$33.6K 0.06% 156
2025
Q3
$728K Buy
5,433
+225
+4% +$29.5K 0.07% 143
2025
Q2
$708K Buy
5,208
+26
+0.5% +$3.43K 0.08% 136
2025
Q1
$687K Buy
5,182
+18
+0.3% +$2.29K 0.08% 134
2024
Q4
$584K Sell
5,164
-164
-3% -$19K 0.07% 151
2024
Q3
$607K Buy
5,328
+39
+0.7% +$4.28K 0.07% 147
2024
Q2
$601K Hold
5,289
0.09% 131
2024
Q1
$601K Sell
5,289
-181
-3% -$20.7K 0.09% 131
2023
Q4
$602K Buy
5,470
+120
+2% +$12K 0.09% 129
2023
Q3
$518K Buy
+5,350
New +$562K 0.09% 139

Other funds holding ABT

Compass Ion Advisors's ABT Position: Q2 2026 in Review

Compass Ion Advisors reduced its Abbott (ABT) stake by 2.1% in Q2 2026, selling an estimated $9.49K and leaving 4,774 shares worth $433K. The position accounts for 0.04% of the portfolio, ranked #205.

Compass Ion Advisors first reported a position in ABT in Q3 2023 and has held it in 12 quarters since. The position peaked at $728K in Q3 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Compass Ion Advisors held 4,774 shares of Abbott worth $433K as of Q2 2026.
  • Compass Ion Advisors sold 104 Abbott shares in Q2 2026, an estimated $9.49K.
  • Abbott made up 0.04% of Compass Ion Advisors's portfolio in Q2 2026, its #205 holding.
  • Compass Ion Advisors first reported a position in Abbott in Q3 2023 and has held it in 12 quarters since.
  • Compass Ion Advisors's Abbott position peaked at $728K in Q3 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.